Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
TheBody.com covers CROI 2009, Montreal, February 8-11, 2009
  • Email Email
  • Glossary Glossary


HIV Treatment Strategies  
Mari Kitahata, M.D., and Jonathan Sterne, M.D. Ever Upward: "When to Start" Debate Turns to CD4+ Cell Count of 500
Dueling studies -- one presented by Mari Kitahata, M.D., the other by Jonathan Sterne, M.D. -- offer strikingly different views on the benefits of HAART initiation at a CD4+ threshold of 500. However, both appear to solidify the wisdom of starting therapy before CD4+ cell count drops below 350.
Read or listen (22 min.):
Expert CROI Interviews

David Wohl, M.D.A Review of Cardiovascular Disease and HIV: Highlights From CROI 2009
David Wohl, M.D., provides a detailed summary.

Joel Gallant, M.D., M.P.H.Which CROI 2009 Studies Are Most Likely to Impact Clinical Care?
Tune in as Joel Gallant, M.D., M.P.H., walks us through some of the most important findings regarding HIV treatment strategies presented at CROI 2009.

Conference Roundup: A Lively Discussion of CROI 2009's Headlines
Join HIV clinician and researcher Pablo Tebas, M.D., Rob Camp and Bob Munk, as they chat about some of the big stories coming out of CROI 2009.

More Top Stories:



Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

  • Email Email
  • Glossary Glossary